Cassadie Moravek

Cassadie Moravek is the Senior Director of Clinical Trial Portfolio and Program Management at the Pancreatic Cancer Action Network (PanCAN).123 In this role, she is involved in various initiatives related to pancreatic cancer research and clinical trials.

Some key points about Cassadie Moravek's work and expertise:

1. Clinical Trial Innovation: She has contributed to publications discussing innovative approaches to clinical trials in pancreatic cancer research. These innovations aim to bring new treatments to patients more efficiently.1

2. Early Detection Research: Moravek has commented on the importance of early detection research for pancreatic cancer. She has highlighted the feasibility of multicenter international consortiums and longitudinal studies in advancing early detection efforts.23

3. Patient Advocacy: She serves as a patient advocate on the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) Panel for Pancreatic Adenocarcinoma.23

4. Expertise in Clinical Trials: Her role at PanCAN involves overseeing the organization's clinical trial portfolio and program management, indicating her deep involvement in the field of pancreatic cancer clinical research.123

5. Collaboration: Moravek is involved in collaborative efforts with various research institutions and cancer centers, working towards improving pancreatic cancer outcomes through research and clinical trials.23

While I don't have specific information about her LinkedIn profile, her professional role and contributions to the field of pancreatic cancer research are well-documented in the provided sources.